ClaripulseClaripulse
MAUDE LookupResourcesBlog
LoginGet Early Access
ClaripulseClaripulse

Product

MAUDE LookupDashboard

Guides

FDA MAUDE DatabasePost-Market SurveillanceSignal Detection

Learn

BlogResourcesWhy Claripulse?

Legal

Privacy PolicyTerms of Service

This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified — do not attempt re-identification. © 2026 Claripulse.

Back to Structural Heart
MAUDE LookupStructural HeartCARPENTIER-EDWARDS BIOPROSTHESIS - AORTIC

CARPENTIER-EDWARDS BIOPROSTHESIS - AORTIC Adverse Events: FDA MAUDE Data

Edwards Lifesciences LLC · Replacement Heart Valve (Surgical/Transcatheter) · First cleared Sep 1991

Total Reports

779

Reports (30d)

2

Active Signals

1

Open Recalls

0

Monthly Report Volume
Event Type Breakdown

What the reports describe · Claripulse analysis

Most commonly reported problems

1

Patient Registry: Valve Explant After 7 Years

patient registry, registry, registry registry, registry patient, explanted

3

reports

2

Adverse Effects Following Valve Explant

adverse, medtronic received, reported medtronic, effects, additional adverse

1

reports

3

Patient Registry: Valve Replacement After 5 Years

patient registry, registry, registry registry, registry patient, valve underwent

1

reports

4

Transcatheter Valve-In-Valve Procedure After 17 Years

procedure implant, transcatheter valve, valve procedure, underwent valve, transcatheter

1

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Detection

Active safety signals

Disproportionate reportinghigh

Evidence

Related research

Carpentier-Edwards Magna Ease bioprosthesis: a multicentre clinical experience and 12-year durability

Antonio Piperata, et al. · European Journal of Cardio-Thoracic Surgery · 2021

Bioprosthetic aortic valve diameter and thickness are directly related to leaflet fluttering: Results from a combined experimental and computational modeling study

Jae Ho Lee, et al. · JTCVS Open · 2020

Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement

Troels Højsgaard Jørgensen, et al. · European Heart Journal · 2021

Final 5-year outcomes following aortic valve replacement with a RESILIA™ tissue bioprosthesis

Krzysztof Bartuś, et al. · European Journal of Cardio-Thoracic Surgery · 2020

Citations indexed from PubMed.

Keep exploring

Related devices in Structural

MitraClip

ABBOTT VASCULAR INC. · 17,746 reports

→

Edwards SAPIEN 3 Ultra Transcatheter Heart Valve

Edwards Lifesciences LLC · 13,096 reports

→

Evolut FX

MEDTRONIC, INC. · 11,918 reports

→

Evolut PRO

MEDTRONIC, INC. · 7,401 reports

→

CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS - AORTIC

Edwards Lifesciences LLC · 6,040 reports

→

CoreValve Evolut

MEDTRONIC, INC. · 4,236 reports

→

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 1 active signal detected right now.

Get Early Access

Understanding this data

What FDA MAUDE data does and does not tell you

How these reports are filed, why raw counts mislead, and the limits to know before drawing conclusions.

→

How a safety signal is detected

What the "Active Signals" count above means and the methods that separate a real signal from noise.

→
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.